| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.31B | +35.9% |
| R&D Expense | $624.1M | +54.4% |
| SG&A Expense | $1.18B | +39.9% |
| Operating Income | -$309.9M | -39.4% |
| Interest Expense | $4.1M | -61.9% |
| Pre-tax Income | -$268.1M | -41.3% |
| Income Tax | -$59.9M | -8722.9% |
| Net Income | -$208.2M | -9.3% |
| EPS (Basic) | -$1.52 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $22.7M | +0.0% |
| Accounts Receivable | $296.5M | -5.6% |
| Inventory | $68.4M | +53.0% |
| Current Assets | $1.50B | +8.8% |
| Total Assets | $2.40B | +44.4% |
| Current Liabilities | $441.2M | +28.2% |
| Total Liabilities | $685.9M | +47.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $215.3M | +58.7% |
| Capital Expenditures | $106.2M | +59.9% |
| Investing Cash Flow | -$132.2M | -196.1% |
| Financing Cash Flow | $47.5M | +57.1% |
| Free Cash Flow | $109.1M | +57.6% |
| +0.7% |
| EPS (Diluted) | -$1.52 | +0.7% |
| Stockholders' Equity |
| $1.71B |
| +43.2% |